Low Prevalence of High-dose Methotrexate Nephropathy in Patients With Malignancy

Iranian Journal of Kidney Diseases, 03/05/2012

The data revealed a low prevalence of acute kidney injury with high–dose methotrexate therapy. In addition, these toxicities were limited to the first and second phases of the RIFLE classification, all of which resolved spontaneously.

Print Article Summary Cat 2 CME Report